Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04416984 |
|---|---|
| Brief Title: | Safety and Efficacy of ALLO-501A Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/Refractory Large B Cell Lymphoma (ALPHA2) (ALPHA2) |
| First Submitted : | May 29, 2020 |
| First Submitted that Met QC Criteria : | June 2, 2020 |
| First Posted : | June 4, 2020 |
| Last Update Submitted that Met QC Criteria : | March 31, 2022 |
| Last Update Posted : | April 8, 2022 |